MYC and B-cell non-Hodgkin lymphoma: Heightened expression of both Myc and Bcl-2 is a highly potent combination (highest in MZCD9+) promoting survival during Myc-driven proliferation and frequently occurs in various B-cell lymphomas (73, 74).